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SUMMARY Acetylsalicylic acid, commonly known as aspirin, can 
induce some hypersensitive reactions with clinical symptoms such as 
urticaria, angioedema, acute bronchospasm, and rarely anaphylactic 
shock. At present, detection of aspirin allergy is still rather difficult 
and requires an adequate clinical history and sensitive in vivo and in 
vitro tests. The aim of the study was to evaluate the diagnostic utility 
of cellular antigen stimulation test (CAST) in the detection of allergic 
reaction mediated by aspirin. Fifty patients (39 women and 11 men) 
with a history of hypersensitivity reaction to aspirin were included in 
the study. Positive scratch test to aspirin was found in 72% (36/50) 
and positive CAST in 58% (29/50) of patients. Both skin scratch 
test and CAST positive results were recorded in 48% (24/50%) and 
negative results in 20% (9/45) of patients. The level of agreement 
between skin scratch test and CAST was fair with Cohen’s kappa of 
0.269 (0.95% CI 0.004-0.533). The observed between-test agreement 
was 66%. It is concluded that CAST-ELISA might be of value as an 
additional test for the detection of aspirin nonallergic hypersensitivity 
in suspected individuals.      
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INTRODUCTION
 There is no doubt that allergies to drugs are 
complex diseases. Drugs can elicit a wide variety 
of different immune and nonimmune reactions (1). 
Acetylsalicylic acid (ASA), commonly known as 
aspirin, can cause reactions which are not IgE-me-
diated. Although IgE is not involved in such non-
allergic hypersensitivity, mast cells and basophils 
may be triggered to release mediators, essentially 
histamine and sulfidoleukotrienes (sLT) (2). The 
latter, SULFIDOLENKOTRIENES as important 
newly-formed mediators in allergies, can cause 
bronchoconstriction, increased vascular permea-
bility, enhanced mucous secretion, and decreased 
mucocilliary transport (3). Moreover, these clinical 
symptoms provoked by ASA are a consequence 
of cyclo-oxygenase inhibition leading to diversion 
of arachidonic acid synthesis to lipo-oxygenase 
pathways with preferential generation of sLT (4). 
The increased population exposure to aspirin has 
resulted in a relevant number of allergic reactions 
every year. Detection of aspirin hypersensitivity in 
daily routine is still rather difficult and is based on 
adequate clinical history and provocation tests, 
essentially skin tests and lymphocyte transfor-
mation test (LTT). Yet, these tests or procedures 
are not always sensitive enough and differ in their 
specificity, safety, reproducibility and efficiency. 
Provocation tests have the best sensitivity but re-
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quire hospitalization of patients and may also be 
potentially harmful (5). In some cases skin test-
ing cannot be performed or may involve additional 
risk. Also, results of LLT may fail to produce clear 
answers. As mentioned earlier, leukotriene me-
tabolism is deeply involved in aspirin intolerance. 
These mediators can be liberated by cross-link-
ing of IgE on basophils or by non-IgE dependent 
mechanisms. Until now, there has been no in vitro 
test based on mediator release (with a few excep-
tions), which could be used as a diagnostic tool. 
The cellular antigen stimulation test (CAST)-ELI-
SA test, as currently used in clinical practice, was 
applied to measure the production of sLT (LTC4 
and its metabolites LTD4 and LTE4) released by 
reactive cells after in vitro stimulation with a spe-
cific allergen. The aim of the study was to evaluate 
the diagnostic sensitivity of CAST in a group of 
patients allergic to aspirin according to clinical his-
tory and skin scratch test (SCR).
PATIENTS AND METHODS
 Patients
 Fifty patients, 39 (78%) women and 11 (22%) 
men, mean age 37 (range 3-78) years, with a his-
tory of hypersensitivity reaction to aspirin were 
included in the study. The clinical reactions after 
drug ingestion developed as urticaria and/or angio-
edema in 22 (44%), dermatitis atopica in 12 (24%), 
rhinitis in five (10%) and medicamentous exan-
thema in 11 (22%) patients. SCR and CAST were 
performed mainly during the period from 1 to 240 
months after allergic reactions. All patients avoid-
ed any medication for 3-10 days prior to testing. 
 Diagnostic tests
 SCR was performed on the volar side of the 
forearm with a previously prepared 10% aspirin 
solution. Test result was read within 20-30 min-
utes (early response), and compared with positive 
control (histamine in a concentration of 1:10000) 
and negative control (buffer solution). Skin reac-
tion to aspirin was considered positive when the 
size of the initial wheal increased in diameter by 3 
mm or greater than 3 mm. The CAST-ELISA was 
done according to the protocol issued by Bühl-
mann laboratories (6). Briefly, the test consists of 
three steps: 1) leukocyte isolation, 2) cell stimula-
tion, and 3) leukotriene determination. In the first 
and second steps, peripheral blood leukocytes are 
isolated after dextran sedimentation of blood sam-
ples and prestimulated with IL-3. Cell suspension 
was aliquoted to separate tubes for basal level 
release (spontaneous release), stimulation con-
trol, and for each drug to be tested. As a positive 
control, the patient’s leukocytes were stimulated 
with anti-IgE receptor antibody. After the incuba-
tion period (40 minutes at 37º C), the samples 
were centrifuged and the supernatant was either 
frozen at -20º C until measurement or immediately 
tested for sLT concentration by ELISA. ELISA was 
performed using precoated microtiter plates (2 x 
96 wells). Blanking reagent, ELISA controls, stan-
dards, and cell supernatants (100 µL) in duplicate 
were added to the plates. Enzyme conjugate (sLT 
conjugated to alkaline phosphatase) and anti sLT 
antibody were also added to each well (50 µL), 
and the plates were incubated for 2 hours at 18-
28º C on a plate rotator. After washing, the sub-
                                                                              Sensitivity according to clinical diagnosis
  Test                 Overall                         Urticaria/             Atopic             Drug                        Rhinitis
  result               sensitivity               �
  
   SCR  +           36/50 (72%)                 16/22 (73%)       11/13 (85%)       4/10 (40%)             5/5 (100%)
   CAST+           29/50 (58%)                 12/22 (54%)       10/13 (77%)       2/10 (20%)             5/5 (100%)
   SCR  +
   CAST+           24/50 (48%)                   9/22 (41%)       9/13  (69%)        1/10 (10%)             5/5 (100%)
   SCR  +
   CAST-            12/36 (27%)                   7/22 (32%)       2/13 (15%)         3/10 (30%)
   SCR  -
   CAST+             5/14 (36%)                   3/22 (14%)       1/13 (8%)          1/10 (10%)
   SCR  -
   CAST-               9/45 (20%)                  3/22 (14%)       1/13 (8%)           5/10 (50%)
     + positive test result; - negative test result
Table 1. Sensitivity of skin scratch test (SCR) and cellular allergen stimulation test (CAST) in determina-
tion of aspirin hypersensitivity
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strate solution (200 µL) was added to the plates 
and incubated for 30 minutes at room tempera-
ture. At the end, stop solution was added (50 µL) 
and color absorbance was expressed as pg/mL of 
the sLT released. The values were extrapolated to 
the sLT standard curve. Results were considered 
positive if exceeding the cut-off range value, 152 
pg/mL for aspirin, calculated after subtraction of 
background. Results were statistically analyzed 
using Cohen′s kappa test.
RESULTS
 Results of SCR and CAST recorded in patients 
with hypersensitivity reactions to aspirin are shown 
in Table 1. Positive SCR results to ASA were found 
in 72% (36/50), and positive CAST results in 58% 
(29/50) of patients. Both SCR and CAST positive 
results were found in 48% (24/50), and negative 
results in 20% (9/45) of patients. Negative CAST 
results were found in 33% (12/36) of patients with 
positive SCR, and negative SCR test results in 
36% (5/14) of patients with positive CAST. The 
lowest test sensitivity for both tests was observed 
in patients which hypersensitivity to aspirin clini-
cally expressed as medicamentous exanthema. 
The overall concordance of SCR and CAST test 
sensitivity was fair with kappa of 0.269 (0.95%CI 
0.004-0.533). The observed agreement between 
the tests was 66%. 
DISCUSSION
 Diagnostic sensitivity of CAST (58%) in our 
study group of patients with a history of aspirin 
hypersensitivity was concordant with diagnostic 
sensitivity of SCR (72%). Similar diagnostic sen-
sitivity of CAST has been reported in patients with 
hypersensitivity to nonsteroidal anti-inflammatory 
drugs (NSAIDs) and in aspirin-intolerant patients 
with airway-related and skin symptoms (4,8-10). 
On the contrary, some other authors did not con-
firm enhanced sLT production by blood leukocytes 
isolated from aspirin-intolerant individuals upon 
incubation with aspirin in vitro (9,11,12). Such a 
discrepancy can be explained by random effect 
recorded in a relatively small number of patients, 
i.e. inhomogeneity of the groups studied (asthma 
and urticaria), and by use of a high aspirin con-
centration that may unmask some intracellular 
mechanisms related to the higher eosinophilia in 
aspirin-intolerant asthma.
 Aspirin-intolerant individuals in our study group 
were tested at different time points after hypersen-
sitivity reaction to aspirin had occurred. We occa-
sionally observed positive SCR and CAST results 
even 20 years after the first drug exposure. It 
means that specific basophil reactivity in some as-
pirin-intolerant individuals may persist for a much 
longer time than three weeks to three months, the 
time suggested as optimal time interval for test-
ing for hypersensitivity reaction to aspirin (13,14). 
Interestingly enough, Luque et al. (15) have de-
scribed T-cell proliferative response to the drug 
in vitro 10 or more years after the occurrence of 
hypersensitivity reaction to the drug.
We conclude that the determination of sLT release 
from the patients’ leukocytes upon incubation with 
aspirin in vitro might be a valuable tool for con-
firmation of nonallergic aspirin hypersensitivity in 
suspected individuals.
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For sun tained healthy skin put the Nivea cream. 
From the Nivea collection of Zlatko Puntijar (1929) 
